NCT05498675 Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study
| NCT ID | NCT05498675 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Friendship Hospital |
| Condition | Sacubitril/Valsartan |
| Study Type | OBSERVATIONAL |
| Enrollment | 180 participants |
| Start Date | 2021-09-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 180 participants in total. It began in 2021-09-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to investigate the effect of sacubitril/valsartan on cardiac function assessed by cardiac magnetic resonance (CMR) in hypertensive patients stratified by BMI.
Eligibility Criteria
Inclusion Criteria: * Patients with essential hypertension * 18-70 years old * No major barriers to provide written consent Exclusion Criteria: * Secondary hypertension, except because of sleep apnea * cardiovascular disease (myocardial infarction, heart failure, stroke or coronary revascularization) within 6 months * Severe concomitant diseases (autoimmune disease, malignancy, late stage of liver diseases, respiratory diseases and digestive diseases) * Unable to understand or comply with the study procedures
Contact & Investigator
Rongchong Huang, M.D.
PRINCIPAL INVESTIGATOR
Beijing Friendship Hospital
Frequently Asked Questions
Who can join the NCT05498675 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Sacubitril/Valsartan. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05498675 currently recruiting?
Yes, NCT05498675 is actively recruiting participants. Contact the research team at rchuang@ccmu.edu.cn for enrollment information.
Where is the NCT05498675 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT05498675 clinical trial?
NCT05498675 is sponsored by Beijing Friendship Hospital. The principal investigator is Rongchong Huang, M.D. at Beijing Friendship Hospital. The trial plans to enroll 180 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.